Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-12-008091)

Filing Details

Accession Number:: 0001225208-12-008091
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-03-20 17:44:59
Reporting Period:: 2012-03-16

Filing Date:: 2012-03-20
Accepted Time:: 2012-03-20 16:44:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
14272	Bristol Myers Squibb Co	BMY	Pharmaceutical Preparations (2834)	220790350

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1176437	B Lewis Campbell	Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.10 Par Value	Acquisiton	2012-03-16	3,500	$28.38	3,500	No	4	M	Direct
Common Stock, $0.10 Par Value	Disposition	2012-03-16	3,500	$33.16	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, $0.10 Par Value	Option (right to buy)	Disposition	2012-03-16	3,500	$0.00	3,500	$28.38

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2012-05-06	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.10 Par Value	2,110	Indirect	By IRA

Footnotes

Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was May 7, 2002.